These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 38811492

  • 1. Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with Epilepsy.
    Klein P, Bourikas D.
    Adv Ther; 2024 Jul; 41(7):2682-2699. PubMed ID: 38811492
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
    Brandt C, Dimova S, Elmoufti S, Laloyaux C, Nondonfaz X, Klein P.
    Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
    [Abstract] [Full Text] [Related]

  • 4. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies.
    Moseley BD, Sperling MR, Asadi-Pooya AA, Diaz A, Elmouft S, Schiemann J, Whitesides J.
    Epilepsy Res; 2016 Nov; 127():179-185. PubMed ID: 27608437
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
    Klitgaard H, Matagne A, Nicolas JM, Gillard M, Lamberty Y, De Ryck M, Kaminski RM, Leclercq K, Niespodziany I, Wolff C, Wood M, Hannestad J, Kervyn S, Kenda B.
    Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
    Biton V, Berkovic SF, Abou-Khalil B, Sperling MR, Johnson ME, Lu S.
    Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
    [Abstract] [Full Text] [Related]

  • 13. Brivaracetam for the treatment of focal-onset seizures: pharmacokinetic and pharmacodynamic evaluations.
    de Biase S, Gigli GL, Valente M.
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):853-863. PubMed ID: 32853036
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study.
    Asadi-Pooya AA, Sperling MR, Chung S, Klein P, Diaz A, Elmoufti S, Schiemann J, Whitesides J.
    Epilepsy Res; 2017 Mar; 131():70-75. PubMed ID: 28279891
    [Abstract] [Full Text] [Related]

  • 15. A review of the pharmacology and clinical efficacy of brivaracetam.
    Klein P, Diaz A, Gasalla T, Whitesides J.
    Clin Pharmacol; 2018 Mar; 10():1-22. PubMed ID: 29403319
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.
    Ben-Menachem E, Mameniškienė R, Quarato PP, Klein P, Gamage J, Schiemann J, Johnson ME, Whitesides J, McDonough B, Eckhardt K.
    Neurology; 2016 Jul 19; 87(3):314-23. PubMed ID: 27335114
    [Abstract] [Full Text] [Related]

  • 17. Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
    Ryvlin P, Dimova S, Elmoufti S, Floricel F, Laloyaux C, Nondonfaz X, Biton V.
    Epilepsia; 2022 Aug 19; 63(8):2024-2036. PubMed ID: 35582748
    [Abstract] [Full Text] [Related]

  • 18. Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis.
    Brandt C, Klein P, Badalamenti V, Gasalla T, Whitesides J.
    Epilepsy Behav; 2020 Feb 19; 103(Pt A):106864. PubMed ID: 31937513
    [Abstract] [Full Text] [Related]

  • 19. Time-course of drug-related psychiatric and behavioral treatment-emergent adverse events during brivaracetam treatment in adults with focal-onset seizures.
    Meador KJ, Dimova S, Bourikas D, Elmoufti S, Floricel F, Laloyaux C, Moseley B, Nondonfaz X, Klein P.
    Epilepsy Behav; 2024 Jul 19; 156():109844. PubMed ID: 38788664
    [Abstract] [Full Text] [Related]

  • 20. Adjunctive brivaracetam - A prospective audit of outcomes from an epilepsy clinic.
    Stephen L, Brodie MJ.
    Epilepsy Behav; 2021 Mar 19; 116():107746. PubMed ID: 33517200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.